白介素26(IL26)活性蛋白
Active Interleukin 26 (IL26)
AK155
- 編號APB695Hu01
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 90%
- 等電點-
- 應用Cell?culture;?Activity?Assays.
- 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價格¥ 1987¥ 4968¥ 9936¥ 29808¥ 74520
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
通過ISO 9001、ISO 13485質量體系認證
活性實驗
用法
Reconstitute in 20mM Tris, 150mM NaCl (PH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務
相關產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| APB695Hu01 | 白介素26(IL26)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPB695Hu01 | 白介素26(IL26)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB695Hu01 | 白介素26(IL26)多克隆抗體 | WB; IHC; ICC; IP. |
| MAB695Hu22 | 白介素26(IL26)單克隆抗體 | WB; IHC; ICC; IP. |
| SEB695Hu | 白介素26(IL26)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCB695Hu | 白介素26(IL26)檢測試劑盒(化學發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMB695Hu | 白介素26(IL26)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Journal of Neuroimmunology | Evaluation of Th17-related cytokines and receptors in multiple sclerosis patients under interferon beta-1 therapy[PubMed: 23177721] |
| Journal of molecular medicine (Berlin, Germany) | IL26 modulates cytokine response and anti-TNF consumption in Crohn's disease patients with bacterial DNA.[pubmed:28879509] |
| The Journal of investigative dermatology | Increased interleukin-26 expression promotes Th17 and Th2-associated cytokine production by keratinocytes in atopic dermatitis[Pubmed: 31465744] |
| Nature Communications | Immunological history governs human stem cell memory CD4 heterogeneity via the Wnt signaling pathway[Pubmed: 32041953] |
| METHOD OF MANUFACTURING BISPECIFIC ANTIBODIES, BISPECIFIC ANTIBODIES AND THERAPEUTIC USE OF SUCH ANTIBODIES[] | |
| Theranostics | IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer[33456560] |